RESUMO
@#Subependymal giant cell astrocytoma is a rare tumor that occurs in the walls of the lateral ventricles, foramen of Monro, and less frequently, in the third ventricle. It is one of the intracranial lesions found in tuberous sclerosis complex (TSC) ─ a rare multisystem genetic disease. We present a rare case of an adult Filipino with cutaneous signs of TSC, who initially presented with signs of increased intracranial pressure. The patient underwent right frontal craniotomy, endoport-assisted excision of the tumor with insertion of a ventriculoperitoneal (VP) shunt. Histopathology was consistent with a subependymal giant-cell astrocytoma WHO grade 1. The general status of the patient improved thereafter – there was the relief of headache and improvement in vision and gross hearing. Subependymal giant cell astrocytoma is a rare tumor of the central nervous system especially in adults, whose diagnosis is based on clinical, radiological, and histological, and immunohistochemical stains. It should be included in the differential diagnosis of a mass near the foramen of Monro. Given the hereditary nature of the disease, genetic counseling is essential when encountering patients with this condition.
Assuntos
Adulto , Astrocitoma , Esclerose TuberosaRESUMO
Large lobar intracerebral hemorrhages (ICHs) can cause rapid neurological deterioration, and affected patients have low rates of survival and functional independence. Currently, the role of surgical intervention in the management patients with lobar ICHs is controversial. Minimally invasive technologies have been developed which may potentially decrease the operative morbidity of ICH surgery. The aim of this case report is to describe the technical aspects of the use of a novel minimally invasive endoport system, the BrainPath (NICO, Indianapolis, IN, USA), through an eyebrow incision for evacuation of a large lobar hematoma. An 84-year-old female presented with a left frontal ICH, measuring 7.5 cm in maximal diameter and 81 cm³ in volume, secondary to cerebral amyloid angiopathy. Through a left eyebrow incision, a miniature modified orbitozygomatic craniotomy was performed, which allowed endoport cannulation of the hematoma from a lateral subfrontal cortical entry point. Endoport-assisted hematoma evacuation resulted in nearly 90% volume reduction and improvement of the patient's functional status at clinical follow-up. We found that minimally invasive endoport technology can be employed in conjunction with conventional neurosurgical skull base principles to achieve safe and effective evacuation of large lobar hematomas in carefully selected patients.